1 / 4

What Factors are Shaping the Trends in the ARDS Market

The Acute Respiratory Distress Syndrome (ARDS) market's characteristics will shift in the upcoming years. Leading pharmaceutical companies in the ARDS market are presently engaged in developing novel medicines with unique MoA to enhance the treatment environment.<br>

xmichael
Download Presentation

What Factors are Shaping the Trends in the ARDS Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. What Factors are Shaping the Trends in the ARDS Market? Acute Respiratory Distress Syndrome Market Trends The ARDS market has few therapy choices despite decades of study. On the market for ARDS, there aren't many therapies. Supportive care combined with mechanical ventilation continues to be the cornerstone of treatment. Further oxygen, prone positioning, the use of paralytics, fluid control, and a method known as positive end-expiratory pressure (PEEP) to help push fluid out of air sacs are all additional ARDS therapy options for patients. These are administered along with continued ARDS therapy for the underlying illness or damage. However, it is anticipated that the Acute Respiratory Distress Syndrome (ARDS) market's characteristics will shift in the upcoming years. Leading pharmaceutical companies in the ARDS market are presently engaged in developing novel medicines with unique MoA to enhance the treatment environment.

  2. Key factors fueling the ARDS market growth The ARDS market is expanding as a result of numerous causes. Rising ARDS prevalence, increased R&D activity, the opportunistic market for novel medications, and other variables are among the important ones. Additionally, the expanding patient population with acute respiratory distress syndrome in the 7MM and the projected approval of novel medicines both contribute to the larger ARDS market size. Below is a full evaluation of these factors- Increasing ARDS prevalence and awareness The ARDS market is expanding mostly due to the rise in prevalence. According to our estimate, the 7MM had roughly 1 million incident cases in 2021. These instances are anticipated to rise by 2032 at a CAGR of 1.5% from 2019 to 2032. As a result, the expanding patient population will present an opportunity for all market leaders to develop novel treatment choices to meet patient needs, which will further fuel the expansion of the ARDS market in the ensuing years. Rising cases of key indications Pneumonia, sepsis, aspiration, trauma, pancreatitis, COVID-19, and other conditions are among the main risk factors contributing to the occurrence of ARDS. The highest number of cases of pneumonia (188K cases), sepsis, and trauma were noted in the US in 2021, according to experts at DelveInsight. These indications' prevalence will rise, expanding the ARDS market. It is projected that ARDS epidemiology will follow the same pattern in the upcoming years. COVID and its impact In addition to the preexisting risk factors, COVID-19 became a significant new risk factor for ARDS in 2020. The epidemic has created the significant potential for major actors in healthcare, including those in the market for ARDS treatments. The market for acute respiratory distress syndrome (ARDS) is driven by reasons such as the increasing prevalence and incidence of acute lung damage, the wide range of risk factors for ARDS, and the quick expansion of the patient population with ARDS. Impact of emerging therapies in the ARDS market Since there is no licensed medication, it is anticipated that the potential development of ARDS medicines with a superior clinical profile will be highly adopted. Leading pharmaceutical goliaths like MediciNova, Edesa Biotech, Light Chain Biosciences, Boehringer Ingelheim, Genentech, Windtree Therapeutics, Biomarck Pharmaceuticals, Athersys, and Healios, as well as Arch Biopartners, APEPTICO Forschung und Entwicklung GmbH, Staidson (Beijing) Biopharmaceuticals, Mesoblast Limited, Avalo Therapeutics, Pluristem Therapeutics, ILTOO Pharma and others.

  3. A rise in the MedTech segment The worldwide ARDS therapy market is anticipated to grow in the coming years. Due to technology breakthroughs, greater healthcare spending, and enhanced healthcare facilities and procedures, pharmaceutical and healthcare industries are evolving quickly. Around the world, many hospitals, clinics, and ambulatory surgical care facilities are using cutting-edge technology and equipment. Way ahead Air pollution is one of the main causes of acute respiratory distress syndrome. The majority of dangerous gas emissions are typically caused by vehicles. Air pollution is increasing the number of ARDS patients as more people use personal mobility. The ARDS market is also anticipated to grow due to lifestyle-related problems, expanding healthcare systems in industrialized nations, and greater awareness of respiratory illnesses. Additionally, to fight COVID-19, pharmaceutical and biotech businesses are working with governments worldwide. There are now 155 compounds and about 115 vaccine candidates in the R&D pipeline. Additionally, the need for commonly used drugs like hydroxychloroquine to treat COVID-19 has also increased. Since there was a dearth of these medications in many industrialized nations, the rising demand for these therapies has provided enormous opportunities for producers of COVID-19 management pharmaceuticals. The market for COVID-19 vaccines and treatment drugs is expected to result in significant future growth for the pharmaceutical and biotechnology industries. The ARDS market is expected to be significantly impacted by this as well. Related Reports: Diagnostic Imaging Equipment Market Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases. Invasive Candidiasis Market "DelveInsight’s ‘Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027’ report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW. Sialidosis Market

  4. DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Filgrastim Biosimilar Insight DelveInsight’s, “Filgrastim Biosimilar Insight, 2022,” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Ventricular Assist Devices (VAD) Market Ventricular Assist Devices (VAD) Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027 Latest Reports by DelveInsight Basal Cell Carcinoma Market | Birch Allergy Market | Bile Duct Neoplasm Market | Gingivitis Market | Lupus Nephritis Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Severe Hypertriglyceridemia (SHTG) Market | Arthralgia Market | Congestive Heart Failure Market | Gingivitis Market | Lupus Nephritis Market | Erythromelalgia Market | AL Amyloidosis Market | Primordial Dwarfism Market | Breast Pumps Market | Hyperuricemia Market | Helicobacter Pylori (H. pylori) Infection Market | AIDS Dementia- Market | Follicular Lymphoma Market | Chronic Pulmonary Hypertension Market | Adrenal Crisis Market | Retinoblastoma Market | Non-Cystic Fibrosis Bronchiectasis Market | Microsatellite Stable Colorectal Cancer Market | Chondrosarcoma Market | Sialidosis Market For more detailed information visit: https://www.delveinsight.com/eular-conference/eular-2022 To know more about our Competitive Services, Click here: Pharma Competitive Intelligence https://www.delveinsight.com/consulting/competitive-intelligence-services Also, take a glance at the Blogs by DelveInsight: ● ● ● ● How Metaverse is Set to Transform the Healthcare Dynamics? Role of Mobile Technology in Hemophilia Management How 3D Bioprinting Technology is Revolutionizing the Healthcare Industry? How Cloud Computing is Transforming the Healthcare Industry Dynamics?

More Related